All patients with primary lung cancer had adenocarcinoma histology, 14 (56%) had a mutation in the epidermal growth factor receptor (EGFR) gene, four (16%) had rearrangements of the anaplastic lymphoma kinase (ALK) gene, and six (28%) did not have any common somatic mutation detected. This evidence concerns the gene EGFR and adenocarcinoma.